DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/dktxnp/china_drug) has announced the addition of the "China Drug Distribution Industry Report, 2012-2015" report to their offering.
According to China Drug Distribution Industry Report, 2012-2015 released by Sino Market Insight, the total sales of Chinese drug distribution industry is estimated to surge 102% over 2011 to RMB1.4288 trillion in 2015.
In 2011, the sales of Chinese drug distribution industry totalized RMB942.6 billion, attaining a YoY rise of 23% if excluding non-comparable factors. In 2012, the figure will grow 10% YoY to RMB1.0367 trillion. It is expected that the figure will hit RMB1.4288 trillion in 2015, and that Chinese drug retailing industry (including non-medicines) will sustain a CAGR of 11% or so in 2013-2015.
In the forthcoming years, drug distribution in China will characterize the followings:
The industry growth will accelerate in rural markets. Among the sales of seven major types of pharmaceuticals in 2011, the sales derived from rural areas climbed 27% over the same period of a year earlier (excluding non-comparable factors) to RMB146.1 billion, with the growth rate rising by roughly 4 percentage points. With the development of rural economy and residents' concern about their own health, the pharmaceutical sale in rural areas is likely to contribute a larger proportion to the total sales.
The concentration degree of drug retail industry will be further enhanced. Of all the sales of top 100 retail chain companies in 2011, the sales of the top 20 enterprises made up 61%, up 3 percentage points. The drug distribution industry tends to be integrated in the future.
The report covers seven chapters and 118 charts, and highlights the market size and competitive landscape of drug distribution industry in China, market status of wholesale and retail market, as well as financial performance, business development and trends of 10 major drug distribution companies.
Key Topics Covered:
1 Overview of Chinese Drug Distribution Industry
2 Development Environment for Chinese Drug Distribution Industry
2.1 Policy Environment
2.2 China's Macroeconomic Environment in 2011-H1 2012
2.3 Forecast of China's Main Macroeconomic Indicators in 2012-2013
3 Market Size and Forecast of Chinese Drug Distribution Industry
3.1 Overall Size
3.2 Sales Structure
3.3 Ownership Structure
3.4 Distribution Structure
3.5 Competitive Landscape
3.6 Investment and Financing
4 Chinese Drug Distribution Industry Segments
4.1 Wholesale Industry
4.2 Retail Industry
5 Chinese Drug Distribution Industry by Region
6 Operation of Pharmaceutical Logistics Companies
6.1 Shanghai Pharmaceuticals Holding Co., Ltd.
6.2 Jointown Pharmaceutical Group Co., Ltd. (600998)
6.3 Nanjing Pharmaceutical Co., Ltd.
6.4 Huadong Medicine Co., Ltd. (000963)
6.5 Harbin Pharmaceutical Group Co., Ltd. (600664)
6.6 China Meheco Co., Ltd. (600056)
6.7 Sinopharm Group Co., Ltd. (01099.HK)
6.8 China Nepstar Chain Drugstore Ltd. (NYSE: NPD)
6.9 Shanghai No. 1 Pharmacy Co., Ltd. (600833)
6.10 Beijing Tongrentang Co., Ltd. (600085)
7 Development Trend of Drug Distribution Industry
7.1 Status Quo
7.2 Development Trend
For more information visit http://www.researchandmarkets.com/research/dktxnp/china_drug